Thor Feels Hammer Of FDA Warning On GMPs, Claims
This article was originally published in The Rose Sheet
Executive Summary
FDA on May 16 published a warning letter submitted to Thor Inc. on May 11, stating problems found in an October 2016 inspection at its facility in Ogden, Utah, and in a review of the firm's website in March.